Jefferies Group LLC Supernus Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$26.37 - $34.22 $2,637 - $3,422	-100 Closed	0 $0
Q3 2021 Sep 21, 2023	SELL	$23.54 - $31.39 $2.65 Million - $3.53 Million	-112,400 Reduced 99.91%	100 $2,000
Q3 2021 Nov 15, 2021	BUY	$23.54 - $31.39 $2,354 - $3,139	100 New	100 $3,000
Q2 2021 Aug 16, 2021	SELL	$26.72 - $33.19 $3.01 Million - $3.73 Million	-112,500 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$24.15 - $31.45 $2.72 Million - $3.54 Million	112,500 New	112,500 $2.95 Million
Q1 2021 May 14, 2021	BUY	$24.15 - $31.45 $2.72 Million - $3.54 Million	112,500 New	112,500 $2.95 Million
Q4 2019 Feb 13, 2020	SELL	$19.93 - $29.13 $678,078 - $991,089	-34,023 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$25.47 - $33.37 $803,069 - $1.05 Million	31,530 Added 1264.74%	34,023 $935,000
Q2 2019 Aug 14, 2019	SELL	$29.96 - $38.87 $1.35 Million - $1.75 Million	-45,148 Reduced 94.77%	2,493 $82,000
Q1 2019 May 15, 2019	BUY	$32.77 - $41.99 $1.56 Million - $2 Million	47,641 New	47,641 $1.67 Million
Q4 2018 Feb 14, 2019	SELL	$30.84 - $49.51 $966,525 - $1.55 Million	-31,340 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$42.7 - $56.55 $1.13 Million - $1.5 Million	26,535 Added 552.24%	31,340 $1.58 Million
Q2 2018 Aug 14, 2018	BUY	$44.1 - $59.85 $211,900 - $287,579	4,805 New	4,805 $288,000
Q1 2018 May 15, 2018	SELL	$37.15 - $46.9 $358,571 - $452,678	-9,652 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$36.4 - $42.6 $351,332 - $411,175	9,652	9,652 $385,000

286

60.7M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.14B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.